Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inhibrx Biosciences, Inc. | 175,000 | reported | 30 May 2024 | tx 4+688,888 |
| Inhibrx, Inc. | 0 | reported | 30 May 2024 | tx 41+200,000−2,892,553 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2024 | SALE | Inhibrx, Inc. | 300,000 | 34.30 USD | anomaly |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 160,000 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 160,000 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 1,735,553 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 6,667 | — | deriv |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 26,667 | — | deriv |
| 29 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 433,888 | — | |
| 29 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 40,000 | — | |
| 29 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 40,000 | — | |
| 30 May 2024 | GRANT_AWARD | Inhibrx Biosciences, Inc. | 175,000 | 0.00 USD | deriv |
| 22 May 2024 | EXERCISE | Inhibrx, Inc. | 2,510 | 34.12 USD | deriv |
| 22 May 2024 | EXERCISE | Inhibrx, Inc. | 2,500 | 34.12 USD | deriv |
| 13 Mar 2024 | EXERCISE | Inhibrx, Inc. | 1,898 | 35.33 USD | deriv |
| 12 Mar 2024 | EXERCISE | Inhibrx, Inc. | 4,152 | 35.25 USD | deriv |
| 12 Mar 2024 | EXERCISE | Inhibrx, Inc. | 19,898 | 35.25 USD | deriv |
| 11 Mar 2024 | EXERCISE | Inhibrx, Inc. | 6,681 | 35.33 USD | deriv |
| 11 Mar 2024 | EXERCISE | Inhibrx, Inc. | 6,877 | 35.30 USD | deriv |
| 08 Mar 2024 | EXERCISE | Inhibrx, Inc. | 2,150 | 35.75 USD | deriv |
| 01 Feb 2023 | SALE | Inhibrx, Inc. | 14,608 | 25.08 USD | |
| 02 Feb 2023 | SALE | Inhibrx, Inc. | 10,120 | 25.40 USD | |
| 01 Feb 2023 | SALE | Inhibrx, Inc. | 13,449 | 24.29 USD | |
| 02 Feb 2023 | SALE | Inhibrx, Inc. | 1,130 | 25.89 USD | |
| 01 Feb 2023 | SALE | Inhibrx, Inc. | 693 | 25.66 USD | |
| 06 Dec 2022 | SALE | Inhibrx, Inc. | 20,927 | 26.83 USD | |
| 06 Dec 2022 | SALE | Inhibrx, Inc. | 17,681 | 27.57 USD |